Download PDF
Ernährung & Medizin 2014; 29(1): 16-20
DOI: 10.1055/s-0033-1361544
wissen
Haug Verlag in MVS Medizinverlage Stuttgart GmbH & Co. KG Stuttgart

Bedeutung von Formuladiäten bei Typ-2-Diabetes

Stephan Martin
Westdeutsches Diabetes- und Gesundheitszentrum, Verbund Katholischer Kliniken Düsseldorf
,
Kerstin Kempf
› Author Affiliations
Further Information

Publication History

Publication Date:
20 March 2014 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Neue Hypothesen gehen davon aus, dass der Typ-2-Diabetes durch eine basale Hyperinsulinämie ausgelöst wird. Bariatrische Operationen, aber auch Formuladiäten führen zu einem schnellen Absinken der basalen Insulinproduktion noch bevor eine signifikante Reduktion des Körpergewichts zu beobachten ist. Formuladiäten bieten daher ein bisher ungenutztes Potenzial in der Diabetestherapie, durch die schnelle Verbesserung der Stoffwechsellage bei den Betroffenen einen Motivationsschub für eine erfolgreiche Änderung des Lebensstils auszulösen.

Schlüsselwörter

Basale Hyperinsulinämie - bariatrische Chirurgie - Diabetes - Formuladiät - Gewichtsreduktion - HbA1c
 

  • Literatur

  • 1 Pories WJ, Dohm GL. Diabetes: have we got it all wrong? Hyperinsulinism as the culprit: surgery provides the evidence. Diabetes Care 2012; 35: 2438-2442
    CrossrefPubMedGoogle Scholar
  • 2 Corkey BE. Diabetes: have we got it all wrong? Insulin hypersecretion and food additives: cause of obesity and diabetes?. Diabetes Care 2012; 35: 2432-2437
    CrossrefPubMedGoogle Scholar
  • 3 Lim EL, Hollingsworth KG, Aribisala BS et al. Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia 2011; 54: 2506-2514
    CrossrefPubMedGoogle Scholar
  • 4 Yki-Järvinen H. Type 2 diabetes: remission in just a week. Diabetologia 2011; 54: 2477-2479
    CrossrefPubMedGoogle Scholar
  • 5 Malandrucco I, Pasqualetti P, Giordani I et al. Very-low-calorie diet: a quick therapeutic tool to improve β cell function in morbidly obese patients with type 2 diabetes. Am J Clin Nutr 2012; 95: 609-613
    CrossrefPubMedGoogle Scholar
  • 6 Henry RR, Wiest-Kent TA, Scheaffer L et al. Metabolic consequences of very-low-calorie diet therapy in obese non-insulin-dependent diabetic and nondiabetic subjects. Diabetes 1986; 35: 155-164
    CrossrefPubMedGoogle Scholar
  • 7 Amatruda JM, Richeson JF, Welle SL et al. The safety and efficacy of a controlled low-energy (‘very-low-calorie’) diet in the treatment of non-insulin-dependent diabetes and obesity. Arch Intern Med 1988; 148: 873-877
    CrossrefPubMedGoogle Scholar
  • 8 Rotella CM, Cresci B, Mannucci E et al. Short cycles of very low calorie diet in the therapy of obese type II diabetes mellitus. J Endocrinol Invest 1994; 17: 171-179
    CrossrefPubMedGoogle Scholar
  • 9 Wing RR, Marcus MD, Salata R et al. Effects of a very-low-calorie diet on long-term glycemic control in obese type 2 diabetic subjects. Arch Intern Med 1991; 151: 1334-1340
    CrossrefPubMedGoogle Scholar
  • 10 Dhindsa P, Scott AR, Donnelly R. Metabolic and cardiovascular effects of very-low-calorie diet therapy in obese patients with Type 2 diabetes in secondary failure: outcomes after 1 year. Diabet Med 2003; 20: 319-324
    CrossrefPubMedGoogle Scholar
  • 11 Jazet IM, Craen AJ de, Schie EM van, Meinders AE. Sustained beneficial metabolic effects 18 months after a 30-day very low calorie diet in severely obese, insulin-treated patients with type 2 diabetes. Diabetes Res Clin Pract 2007; 77: 70-76
    CrossrefPubMedGoogle Scholar
  • 12 Miyashita Y, Koide N, Ohtsuka M et al. Beneficial effect of low carbohydrate in low calorie diets on visceral fat reduction in type 2 diabetic patients with obesity. Diabetes Res Clin Pract 2004; 65: 235-241
    CrossrefPubMedGoogle Scholar
  • 13 Hussain TA, Mathew TC, Dashti AA et al. Effect of low-calorie versus low-carbohydrate ketogenic diet in type 2 diabetes. Nutrition 2012; 28: 1016-1021
    CrossrefPubMedGoogle Scholar
  • 14 Kempf K, Schloot NC, Gärtner B et al. Meal replacement reduces insulin requirement, HbA1c and weight long-term in type 2 diabetes patients with >100 U insulin per day. J Hum Nutr Diet 02.08.2013; DOI: 10.1111/jhn.12145. [Epub ahead of print]
    PubMedGoogle Scholar
  • 15 InterAct Consortium. Consumption of sweet beverages and type 2 diabetes incidence in European adults: results from EPIC-InterAct. Diabetologia 2013; 56: 1520-1530
    CrossrefPubMedGoogle Scholar
  • 16 Jackness C, Karmally W, Febres G et al. Very low-calorie diet mimics the early beneficial effect of Roux-en-Y gastric bypass on insulin sensitivity and β-cell function in type 2 diabetic patients. Diabetes 2013; 62: 3027-3032
    CrossrefPubMedGoogle Scholar
  • 17 Lingvay I, Guth E, Islam A, Livingston E. Rapid improvement in diabetes after gastric bypass surgery: Is it the diet or surgery? . Diabetes Care 2013; 36: 2741-2747
    PubMedGoogle Scholar
  • 18 Lips MA, Groot GH de, Klinken JB van et al. Calorie restriction is a major determinant of the short-term metabolic effects of gastric bypass surgery in obese type 2 diabetic patients. Clin Endocrinol (Oxf) 2013; DOI: 10.1111/cen.12254. [Epub ahead of print]
    PubMedGoogle Scholar